Autor der Publikation

NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy

, , , , , , , , , , und . Acta Oncologica, 54 (9): 1658--1664 (2015)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Keine Personen gefunden für den Autorennamen Bandurska-Luque, Anna
Eine Person hinzufügen mit dem Namen Bandurska-Luque, Anna
 

Weitere Publikationen von Autoren mit dem selben Namen

Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis, , , , , , , , , und 1 andere Autor(en). International Journal of Radiation Oncology* Biology* Physics, 92 (5): 1165--1174 (2015)NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy, , , , , , , , , und 1 andere Autor(en). Acta Oncologica, 54 (9): 1658--1664 (2015)FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy, , , , , , , , , und 1 andere Autor(en). Radiotherapy and Oncology, 122 (3): 437--444 (2017)Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients, , , , , , , , , und 1 andere Autor(en). Clinical and translational radiation oncology, (2019)FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients, , , , , , , , , und 1 andere Autor(en). Radiotherapy and Oncology, (2019)FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy, , , , , , , , , und 1 andere Autor(en). Radiotherapy and Oncology, 122 (3): 437--444 (2017)NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy, , , , , , , , , und 1 andere Autor(en). Acta Oncologica, 54 (9): 1658--1664 (2015)FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients, , , , , , , , , und 1 andere Autor(en). Radiotherapy and Oncology, (2019)Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients, , , , , , , , , und 1 andere Autor(en). Clinical and translational radiation oncology, (2019)